First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer

J. Bergh; Per-Ebbe Jönsson; E. Lidbrink; M. Trudeau; W. Eiermann; D. Brattstrom; J. Lindemann; F. Wiklund; R. Henriksson

doi:10.1158/0008-5472.SABCS-09-23

First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer

J. Bergh, Per-Ebbe Jönsson, E. Lidbrink, M. Trudeau, W. Eiermann, D. Brattstrom, J. Lindemann, F. Wiklund, R. Henriksson

Surgery

Research output: Contribution to journal › Published meeting abstract › peer-review

Original language	English
Pages (from-to)	490S-491S
Journal	Cancer Research
Volume	69
Issue number	24
DOIs	https://doi.org/10.1158/0008-5472.SABCS-09-23
Publication status	Published - 2009
Event	32nd Annual San Antonio Breast Cancer Symposium - San Antonio, TX, United States Duration: 2009 Dec 9 → 2009 Dec 13

Subject classification (UKÄ)

Surgery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.SABCS-09-23

Cite this

Bergh, J., Jönsson, P.-E., Lidbrink, E., Trudeau, M., Eiermann, W., Brattstrom, D., Lindemann, J., Wiklund, F., & Henriksson, R. (2009). First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer. Cancer Research, 69(24), 490S-491S. https://doi.org/10.1158/0008-5472.SABCS-09-23

@article{77465a13b2594c79a1193b1532f3a68d,

title = "First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer",

author = "J. Bergh and Per-Ebbe J{\"o}nsson and E. Lidbrink and M. Trudeau and W. Eiermann and D. Brattstrom and J. Lindemann and F. Wiklund and R. Henriksson",

year = "2009",

doi = "10.1158/0008-5472.SABCS-09-23",

language = "English",

volume = "69",

pages = "490S--491S",

journal = "Cancer Research",

issn = "1538-7445",

publisher = "American Association for Cancer Research Inc.",

number = "24",

note = "32nd Annual San Antonio Breast Cancer Symposium ; Conference date: 09-12-2009 Through 13-12-2009",

}

Bergh, J, Jönsson, P-E, Lidbrink, E, Trudeau, M, Eiermann, W, Brattstrom, D, Lindemann, J, Wiklund, F & Henriksson, R 2009, 'First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer', Cancer Research, vol. 69, no. 24, pp. 490S-491S. https://doi.org/10.1158/0008-5472.SABCS-09-23

First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer. / Bergh, J.; Jönsson, Per-Ebbe; Lidbrink, E. et al.
In: Cancer Research, Vol. 69, No. 24, 2009, p. 490S-491S.

Research output: Contribution to journal › Published meeting abstract › peer-review

TY - JOUR

T1 - First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer

AU - Bergh, J.

AU - Jönsson, Per-Ebbe

AU - Lidbrink, E.

AU - Trudeau, M.

AU - Eiermann, W.

AU - Brattstrom, D.

AU - Lindemann, J.

AU - Wiklund, F.

AU - Henriksson, R.

PY - 2009

Y1 - 2009

U2 - 10.1158/0008-5472.SABCS-09-23

DO - 10.1158/0008-5472.SABCS-09-23

M3 - Published meeting abstract

SN - 1538-7445

VL - 69

SP - 490S-491S

JO - Cancer Research

JF - Cancer Research

IS - 24

T2 - 32nd Annual San Antonio Breast Cancer Symposium

Y2 - 9 December 2009 through 13 December 2009

ER -